BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,365,416 | -18.8% | 146,663 | +2.1% | 0.22% | -10.9% |
Q2 2023 | $9,074,825 | +26.4% | 143,589 | -10.0% | 0.25% | +19.3% |
Q1 2023 | $7,180,584 | +127713.9% | 159,604 | +24.5% | 0.21% | +17.6% |
Q4 2022 | $5,618 | -99.9% | 128,242 | +14.2% | 0.18% | -26.7% |
Q3 2022 | $7,399,000 | +10.4% | 112,288 | -15.3% | 0.24% | +18.8% |
Q2 2022 | $6,699,000 | -17.3% | 132,621 | +4.5% | 0.20% | +5.2% |
Q1 2022 | $8,104,000 | -38.8% | 126,868 | +2.6% | 0.19% | -27.5% |
Q4 2021 | $13,246,000 | +7.2% | 123,669 | +2.9% | 0.26% | +3.5% |
Q3 2021 | $12,355,000 | -12.0% | 120,169 | -24.7% | 0.26% | +1.6% |
Q2 2021 | $14,037,000 | -4.5% | 159,583 | +5.6% | 0.25% | -7.4% |
Q1 2021 | $14,693,000 | -23.9% | 151,112 | -12.2% | 0.27% | -25.9% |
Q4 2020 | $19,312,000 | +10.9% | 172,198 | -8.3% | 0.37% | -20.6% |
Q3 2020 | $17,414,000 | +31.2% | 187,849 | +10.4% | 0.46% | +22.5% |
Q2 2020 | $13,268,000 | +14.3% | 170,107 | -14.3% | 0.38% | -9.4% |
Q1 2020 | $11,606,000 | – | 198,467 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |